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Abstract DNA methylation plays an integral role in
development and aging through epigenetic regulation of
genome function. DNA methyltransferase 1 (Dnmt1) is the
most prevalent DNA methyltransferase that maintains
genomic methylation stability. To further elucidate the
function of Dnmt1 in aging and age-related diseases, we
exploited the Dnmt1+/− mouse model to investigate how
Dnmt1 haploinsufficiency impacts the aging process by
assessing the changes of several major aging phenotypes.
We confirmed that Dnmt1 haploinsufficiency indeed
decreases DNA methylation as a result of reduced Dnmt1
expression. To assess the effect of Dnmt1 haploinsuffi-
ciency on general body composition, we performed dual-
energy X-ray absorptiometry analysis and showed that
reduced Dnmt1 activity decreased bone mineral density and
body weight, but with no significant impact on mortality or
body fat content. Using behavioral tests, we demonstrated
that Dnmt1 haploinsufficiency impairs learning and mem-
ory functions in an age-dependent manner. Taken together,
our findings point to the interesting likelihood that reduced
genomic methylation activity adversely affects the healthy
aging process without altering survival and mortality. Our
studies demonstrated that cognitive functions of the central
nervous system are modulated by Dnmt1 activity and
genomic methylation, highlighting the significance of the
original epigenetic hypothesis underlying memory coding
and function.
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Aging epigenetics is an emerging research theme that bears
the promise for unraveling the molecular causes of many
age-related health problems in the future (Rando 2010).
Epigenetic mechanisms represent the molecular interface
mediating gene–environment interactions throughout the
lifecycle. Aberrant epigenetic signaling plays a crucial role
in tumorigenesis (Bjornsson et al. 2004), and it can also
contribute to cellular senescence and organismal aging
(Fraga and Esteller 2007). DNA methylation is a major
epigenetic event and has been shown to play important
roles in fundamental cellular processes such as differenti-
ation, proliferation, and senescence by modulating both
local and genome-wide gene transcription through the
transfer of methyl groups to cytosines within CpG
dinucleotides (Robertson 2005). The biological significance
of DNA methylation has been clearly documented by the
embryonic lethality in mice lacking major DNA methyl-
transferases (Dnmt1, 3a, and 3b; Li et al. 1992; Okano et al.
1999).
During early embryogenesis, DNA methylation patterns
undergo dramatic changes (Santos et al. 2002). Upon
completion of organogenesis, tissue-specific methylation
profiles are established and maintained in a relatively stable
pattern. DNA methylation is catalyzed by several Dnmts,
including Dnmt1 that preferentially methylates hemimethy-
lated DNA and two de novo methyltransferases, Dnmt3a
and Dnmt3b, which have been shown to methylate
previously unmethylated sequences (Okano et al. 1999).
The great fidelity with which DNA methylation patterns in
mammals are inherited after each cell division is ensured by
the maintenance DNA methyltransferase Dnmt1. However,
it has been shown that the aging cell undergoes a DNA
methylation drift with generally an overall decrease in total
genomic 5-methyl-2′-deoxycytidine (5-mdC) content in
many tissue types (Mays-Hoopes et al. 1986; Rath and
Kanungo 1989; Wang et al. 2008; Wilson and Jones 1983).
It has been postulated that a passive demethylation of
heterochromatic DNA may occur as a consequence of a
progressive loss of Dnmt1 efficacy or erroneous targeting of
the enzyme (Fraga and Esteller 2007). In addition, studies
in cultured aging human fibroblasts have revealed that a
gradually reduced Dnmt1 expression and activity occur
with increased population doublings (an in vitro measure-
ment of cellular age; Casillas et al. 2003). Despite the fact
that many studies have demonstrated the critical role of
Dnmt1 activity in regulating cancer cell growth and
survival, Dnmt1 function with respect to aging studies
awaits further investigations.
Understanding the molecular interface mediating aging
and age-related health disorders has emerged as one of the
major focuses in biomedical research. It is now well
established that aberrant DNA methylation processes are
often a causal factor in many forms of cancer as well as
several major neurological disorders (Robertson 2005). In
addition, it has been long hypothesized that the methylation
pattern in neuronal DNA is an important regulator of
cognitive functions such as learning and memory (Holliday
1999). The epigenetic component of cognitive function
has gained experimental support from several important
studies recently (Feng et al. 2007;F e n ge ta l .2010;L i ue t
al. 2009; Peleg et al. 2010;R e u le ta l .2009). Several
recent papers have also identified abnormal DNA methyl-
ation events in neuronal cells associated with aging and
age-related neurodegenerative disorders such as Alz-
heimer’s disease (Mastroeni et al. 2010;S i e g m u n de ta l .
2007; Silva et al. 2008). In addition, epigenetic contribu-
tions to metabolic syndromes ranging from insulin
resistance to cardiovascular diseases are also beginning
to be explored with great interest to provide mechanistic
insights into the environmental causes of chronic human
diseases (Gluckman et al. 2009; Sinclair et al. 2007;
Stenvinkel et al. 2007). Here we focus on assessing the
functional and biological significance of DNA methylation
in healthy aging by investigating how Dnmt1 haploinsuf-
ficiency impacts general body composition, cognitive
function and other health conditions during the aging
process. Our results clearly support the likelihood that
insufficient DNA methylation can lead to early onset of
sub-optimal health conditions during the aging process
including compromised cognitive function.
Materials and methods
Mice breeding and genotyping
Normal aging C57BL/6 mice at three different ages (6, 12,
and 18 months old, respectively) were purchased from the
National Institute on Aging. Dnmt1+/− mice, bred onto a
C57BL/6 background, were obtained from the Jackson
Laboratory (Stock# 002198) at 2 months of age (Bar
Harbor, ME). Female Dnmt1+/− mice were bred with male
Dnmt1+/+ C57BL/6 mice. Tail DNAwas extracted from the
progenies for genotyping analysis using a PCR-based
protocol provided by the Jackson Laboratory. Dnmt1+/−
mice and Dnmt1+/+ littermate controls were maintained
under identical conditions. Standard pellet mouse feed
(Harlan Teklad 7012) and water were available ad libitum,
and lighting cycle was the standard 12 h light/dark. All
mice were housed in a specific pathogen-free environment
at the University of Alabama at Birmingham Animal Care
Facility. Sentinel mice were tested regularly for antibodies
to murine viral pathogens, and all tests were negative
throughout the experiment. All studies were performed with
350 Clin Epigenet (2011) 2:349–360approval from the Institutional Animal Care and Use
Committee of the University of Alabama at Birmingham.
Body composition analysis using dual-energy X-ray
absorptiometry
In vivo body composition (total body fat, soft-lean tissue,
and bone mineral density) of mice was determined using a
PIXImus densitometer (GE-Lunar PIXImus, Madison, WI)
as previously described (Huffman et al. 2007; Nagy and
Clair 2000). All body composition scans for both male and
female mice were performed at 6 months of age. Mice were
anesthetized with isoflurane (2%) and placed in a prostrate
position on the imaging plate. A total body scan was done
for approximately 5 min for each mouse. Body composition
data were analyzed to determine fat and lean tissue masses
as well as bone mineral density (BMD).
Mouse behavioral tests
To eliminate sex-dependent variations and potential hor-
monal impact on cognitive performance, we only focused
on male mice in this study using several different cognitive
tasks including the Morris water maze, the Barnes maze,
and the eight-arm radial maze tests to determine learning
and memory function, including long-term memory perfor-
mance as previously reported (Liu et al. 2002). Briefly, in
the water maze, mice at different ages were trained for four
trials per day to swim from one of the four starting points of
the pool to find a fixed, hidden platform, submerged below
the water in one of the quadrants of the pool. After trial 20
on day 5, the fourth trial is immediately followed by a
probe trial (no escape platform) for 1 min. Mice with intact
memory function typically remain searching for a much
longer time in the “correct” quadrant, whereas impaired
mice would explore more evenly among the four quadrants.
Learning of the task was evaluated by recording the latency
to find the platform, the path length, and percentage of
trials that each animal found the platform. We also
employed the Barnes maze as an alternative cognitive test
for mice that were subjected to the water maze test at an
earlier age to avoid residual memory retained from previous
swimming trainings (van Groen et al. 2002). The Barnes
maze used in this study was adapted from the one
developed for rats (Barnes 1979). The elevated round
platform had a diameter of 140 cm, and the escape holes
were distributed along the rim of the platform. Only one of
them, the correct escape hole, has a modified home cage
attached under it. Mice were trained to escape from the
open platform (the start position is in the middle of the
platform) to the escape cage; there were four trials per day
for 5 days, similar to the water maze. The mice were
removed from the maze after escaping or after 4 min had
passed, whichever came first. Learning of the task was
evaluated by recording the latency to find the correct escape
hole, the path length, and percentage of trials that each
animal found the correct hole. Four trials were run per day.
The learning of the maze took an average of 5 days.
Additionally, a “wet” version of the eight-arm radial maze
was used in the latest behavioral tests by placing an eight-
arm radial water maze in a water pool according to the
protocol reported previously (Shukitt-Hale et al. 2004). In
this task, the mice were required to find the escape platform
in the correct arm. They had four trials per day for 5 days.
The mice started in four different arms each day, which
were pseudo-randomly assigned. An entry into an incorrect
arm was recorded a reference memory error, and an entry
into an arm where it had been before was referred to as a
working memory error. Following behavioral tests, the mice
were sacrificed. The brain (divided into cortex and
hippocampus) and liver were removed and used for gene
expression analysis and also DNA methylation analysis as
described below. Livers were collected from 22 months of
mice for assessing tumor formations.
Hematoxylin and eosin staining
Mice livers were fixed in 10% formalin for over 24 h and
embedded in paraffin prior to standard hematoxylin and
eosin (H&E) staining. Deparaffinized sections (5 μm) were
stained routinely with H&E for pathological evaluation by
three independent observers who were blinded to the source
of the tissues.
Gene expression analysis
Total tissue RNAwas purified using the TriPure Isolation
Reagent (Roche Applied Science). Extracted RNA was
digested with RQ1 RNase-free DNase (Promega, Madi-
son, WI) to remove residual DNA contamination. After
digestion, DNase was removed by phenol–chloroform
extraction. RT-PCR was done as described previously
(Liu et al. 2004). RNA (∼1 μg) was reverse transcribed in
20 μl of final reaction volume using the SuperScript
preamplification system for first-strand cDNA synthesis
(Invitrogen, Carlsbad, CA). cDNA was subjected to
quantitative real-time PCR analysis using the ABI Prism
7900 Sequence Detection System (PE Applied Biosys-
tems, Foster City, CA) and by following the Assays-on-
Demand protocol. Gapdh was included as a control
reference gene to normalize the amount and the quality
of cDNA. Primers for Dnmt1 and Gapdh were preopti-
m i z e da n dm i x e dw i t hT a q M a nM G Bp r o b e( F A Md y e
labeled, PE Applied Biosystems). Quantitative data were
analyzed using the Sequence Detection System software
version 2.1 (PE Applied Biosystems). This relative
Clin Epigenet (2011) 2:349–360 351q u a n t i f i c a t i o nw a sb a s e do nt h er a t i oo ft h em e a nv a l u eo f
the target gene (Dnmt1) to the mean value of the
endogenous control (Gapdh) gene in each sample.
Genomic DNA methylation analysis
Genomic DNAwas extracted using a Wizard genomic DNA
extraction kit (Promega). 5-mdC levels were measured by
liquid chromatography–mass spectrometry (LC-MS) analy-
sis as reported previously (Song et al. 2005). Briefly,
purified DNA was treated with RNase A/T1, followed by
digestion with nuclease P1 and calf intestinal alkaline
phosphatase to convert gDNA into component nucleosides.
5-mdC content was expressed as a ratio to deoxyguanosine
as previously described (Song et al. 2005).
Statistical analysis
For DNA methylation analysis, differences of the means
between the age groups were evaluated by using the
analysis of variance (ANOV A, SAS 9.1) and considered
significant if p<0.05. The behavioral results were analyzed
by using the Systat program and one-way ANOV A. For
body composition studies, a two-sample t test or Wilcoxon
rank sums test was used to compare mean differences or
distribution differences between Dnmt1+/− mice and
Dnmt1+/+ groups for variables weight, BMD, and fat that
were stratified by gender variable using SAS 9.1.
Results
Dnmt1 haploinsufficiency reduces genomic 5-mdC content
and adversely impacts cognitive performance
We obtainedDnmt1+/− heterozygousknockoutmicefromthe
Jackson Laboratory for all experiments in this study.
Following continuous breeding, Dnmt1+/− mice colonies
and corresponding Dnmt1+/+littermatecontrol colonieswere
maintainedunderidenticalconditions.Tomeasuregenomic5-
mdC content, DNAwas extracted and subjected to LC-MS
analysis as reported previously (Song et al. 2005). We first
showed that 5-mdC content decreased with age in the liver,
hippocampus, and brain cortex in normal C57BL/6 mice at
7, 13, and 19 months of age, respectively, which is consistent
with previous observations (Mays-Hoopes et al. 1986;
Wilson and Jones 1983;F i g .1a). An age-related reduction
in learning and memory in mice has been demonstrated
previously using the water maze test. Our eight-arm radial
 Fig. 1 a Changes in genomic content of 5-mdC in brain cortex,
hippocampus, and liver during normal aging (n=4). b Comparisons of
mRNA levels between age-matched Dnmt1+/− mice and Dnmt1+/+
mice at three different ages, respectively. *p<0.05
352 Clin Epigenet (2011) 2:349–360maze memory test also revealed a steady age-dependent
decline in learning and memory functions as indicated by the
decreasing percentage of mice that passed this cognitive test
with increasing age (summarized in Table 1), which confirms
that there exists a functional correlation between genomic
DNA methylation levels and cognitive performance during
the aging process. To determine whether Dnmt1 haploinsuf-
ficiency reduced genomic methylation levels, hippocampus
and brain cortex gDNA from both the Dnmt1+/− mice and
Dnmt1+/+ littermate controls were subjected to similar
analysis. As summarized in Table 2, Dnmt1 haploinsuffi-
ciency did not cause a corresponding 50% decrease in
genomic 5-mdC content, but an obvious reduction in 5-mdC
level was consistently seen among the three age groups
examined. The age-dependent loss of genomic 5-mdC in the
brain cortex of Dnmt1+/+ mice in Table 2 was also
consistent with the pattern of methylation changes presented
in Fig. 1a, and a similar trend was observed in the
hippocampus but at a smaller scale. Compared with age-
matched control mice, Dnmt1 expression in Dnmt1+/− mice
was also dramatically reduced at the mRNA level in three
different age groups, as determined by real-time RT-PCR
analysis (Fig. 1b).
Impact of Dnmt1 haploinsufficiency on body compositions
and general health conditions
As a first approach to assessing the role of Dnmt1 in
healthy aging, age- and gender-matched mice between these
two genotypes were used for comparative analysis of
changes in body composition. To evaluate how Dnmt1
haploinsufficiency affects overall body composition, we
applied dual-energy X-ray absorptiometry analysis to
measure BMD and body fat deposition in Dnmt1+/− mice
and Dnmt1+/+ littermate controls. We used a two-sample t
test or Wilcoxon rank sums test to compare mean differ-
ences or distribution differences between Dnmt1+/− mice
and Dnmt1+/+ groups for the variables weight, BMD, and
fat that were stratified by gender variable. As summarized
in Fig. 2, we found that the body weight of Dnmt1+/+ mice
Table 1 Age-related memory function changes in normal mice tested
by eight-arm radial maze assay
Age group (month) Percentage of mice learned the task
by the end of the experiment (%)
7 100
13 83.3
19 33.3
Each mouse was subjected to this test and was considered to be
competent in learning and memory function if they learned to retrieve
the food pellet accurately from the eight-arm device by the end of the
21-day period of the experiment. Twelve mice were included in each
age group. The results were based on the percentage of mice that
passed the test criteria and no statistical analysis was applied
Fig. 2 Comparative analysis of body weight (g), BMD (mg/cm
2), and
fat deposition (%) between Dnmt1+/+ and Dnmt1+/− mice. Total
number of mice used in the analysis was: male Dnmt1+/+ (n=16),male
Dnmt1+/− (n=16), female Dnmt1+/+ (n=13), and male Dnmt1+/− (n=
19). *p<0.05
Table 2 Comparative analysis of genomic 5-mdC levels between
Dnmt1+/+ and Dnmt1+/− mice
Age (month) Percentage of genomic 5-mdC
Dnmt1+/+ Dnmt1+/−
Brain cortex
3 4.62 4.52
11 4.32 4.07
17 4.24 4.1
Brain hippocampus
3 4.08 3.98
11 3.97 3.84
17 3.85 3.87
The % value of 5-mdC is expressed as a ratio of 5-mdC to all
deoxyguanosine (dG). Each value represents the mean of the results
from two different mice, and no statistical analysis was applied
Clin Epigenet (2011) 2:349–360 353was significantly higher than that of Dnmt1+/− mice both
for the female group (p=0.0012) and the male group (p=
0.0069). Significant differences were also observed for
BMD between the two genotype groups both for the female
mice (p=0.04) and the male mice (p=0.03). However, no
significant differences were observed in body fat content
between these two genotypes for either the female mice (p=
0.19) or the male mice (p=0.38). Interestingly, the female
mice tend to have more body fat content and lower BMD
than their genotype-matched male counterparts (Fig. 2).
Additionally, the pathological examination of sacrificed
mice upon tissue collection revealed that sporadic forms of
health abnormalities (liver and lung tumors, cataract, testicular
inflammation,etc.) were present in old Dnmt1+/−mice but not
in the Dnmt1+/+ mice (Table 3 and Fig. 3). Apart from these
phenotypes, we found no differences in the overall survival or
mortality rate between the Dnmt1+/+ and Dnmt1+/− groups
up to 22 months of age, suggesting that optimal Dnmt1
activity is selectively important for maintaining the proper
conditions of specific physiological functions.
Cognitive impairment in Dnmt1+/− mice increased
with age
A genome-wide decline in DNA methylation occurs in the
brain during normal aging that coincides with a functional
decline in learning and memory with age (Liu et al. 2009).
It has long been speculated that DNA methylation in
neurons might be involved in memory encoding (Holliday
1999). To assess the impact of Dnmt1 haploinsufficiency on
cognition, both Dnmt1+/− mice and Dnmt1+/+ littermate
controls were tested in the water maze test to determine
their cognitive status. Our preliminary studies based on a
group of age- and gender-matched Dnmt1+/− and Dnmt1+/+
mice (five mice in each group) indicated to us a significant
impairment of learning and memory function at 12 months of
age due to Dnmt1 haploinsufficiency (p<0.05; Fig. 4). We
followed up this intriguing observation by including more
mice (15 mice in each group) and by starting at an earlier
age (i.e., first cognitive assessment at 6 months of age). The
water maze test results presented in Fig. 4, however,
indicated that no significant differences were present in
the learning and memory abilities (i.e., the learning
curves) between these two groups at 6 months of age
throughout the trials over 8 days of training. The
swimming speeds were not significantly different be-
tween the two groups of mice (19.0±2.1 and 17.8±
2.2 m/min, for Dnmt1+/− and Dnmt1+/+, respectively).
The only significant difference was seen in the reversal
training at the end of the experiment (day 8) showing
that the Dnmt1+/− mice did significantly better than the
control Dnmt1+/+ mice in this part of the task (Fig. 5),
which might be related to the possibility that the normal
mice spent more time to explore around the previously
correct quadrant whereas the Dnmt1+/− mice explored the
quadrants randomly to find the new correct escape
quadrant more rapidly.
Given that our initial study based on five mice indicated
a significant impairment of cognitive function at 12 months
of age, we reasoned that there might be an age-dependent
cognitive impairment due to Dnmt1 haploinsufficiency.
Thus, to test the possibility that the impairment of cognitive
function due to Dnmt1 haploinsufficiency may manifest
later during the aging process, we decided to test the two
15-mice groups at 12 months of age again. Since mice
generally do better in subsequent water maze tests
following previous swimming trainings (van Groen et al.,
unpublished observations), we employed the Barnes maze
as a novel cognitive test for these groups of mice at
12 months of age. Interestingly, the results from this new
cognitive test revealed that Dnmt1+/− mice had slightly, but
significantly (p=0.038), impaired cognitive functions com-
pared to the Dnmt1+/+ mice (Fig. 6), suggesting that their
learning and memory abilities were indeed affected by
Dnmt1 haploinsufficiency at 12 months of age, which is
consistent with our earlier results (shown in Fig. 4). No
Fig. 3 Histological comparisons of the liver from Dnmt1+/+ and
Dnmt1+/− mice at 22 months of age assessed by H&E staining. The
histological structure of the liver from Dnmt1+/+ mice (left) is clear
and the solid line represents normal central vein in hepatic lobule. The
structure of the hepatic lobule from Dnmt1+/− mice (right) was
destructed by invasive tumor. Dotted lines indicate representative
necrosis area and small arrowheads point to tumor bulks in the liver.
Representative pictures were taken using a Nikon Eclipse E400
inverted microscope and DXM1200 digital camera
Table 3 Comparative analysis of age-related health problems between
Dnmt1+/+ and Dnmt1+/− mice at the age of 22 months
Abnormality Dnmt1+/+ (n=7) Dnmt1+/− (n=8)
Severe inflammation 0 2
Cataract 0 1
Liver tumor 0 3
Lung tumor 0 1
Mortality 0 0
354 Clin Epigenet (2011) 2:349–360significant differences were present in the walking speeds
(5.5±1.2 and 6.1±1.2 m/min, for Dnmt1+/− and Dnmt1+/+,
respectively) and in the number of errors between the groups
(not shown). To further validate this observation, the same
groups of mice were retested again for their cognitive
functioning at 18 months of age using the wet version of an
eight-arm radial maze. Similarly, we noticed that Dnmt1+/−
mice exhibited significantly impaired cognitive functions as
compared to the Dnmt1+/+ control mice (Fig. 7). It is
worthwhile to point out that the poorer performance by
Dnmt1+/− mice was obvious throughout the experimental
periods (p<0.001; 5 days in total), but that Dnmt1+/+ mice
started their performance at a significantly lower escape
latency than the Dnmt1+/− mice (Fig. 7), confirming a
preexisting difference in long-term memory (i.e., cognitive
functioning) between these two groups prior to the test.
Swimming speeds were similar between the two groups,
12.0±1.7 and 11.9±1.5 m/min for Dnmt1+/− and Dnmt1+/+,
respectively. But it should be noted that even if they were
s i g n i f i c a n t l yi m p a i r e dc o m p a r e dt ot h eD n m t 1 + / +m i c e ,t h e
Dnmt1+/− mice did learn the task at the end of the training
(significant improvement in the escape latency, p<0.001).
Taken together, these studies suggest that Dnmt1 haploin-
sufficiency had more pronounced detrimental effects on
cognitive function at later ages (i.e., 12 months and later) but
not at an early age (6 months).
Discussion
In this study, we examined the functional impact of Dnmt1
haploinsufficiency and genomic DNA methylation alterations
Fig. 4 Assessment and comparison of cognitive functions using the
water maze test between Dnmt1+/+ and Dnmt1+/− mice at 12 months
of age. Five mice in each genotype group were tested. Statistical
analyses of the escape latency differences between these two groups
were performed using the Systat program by ANOV A. By the end of
the 5-day trial period, Dnmt1+/− mice displayed a significantly
delayed escape latency time than the age- and gender-matched
Dnmt1+/+ mice (i.e., on the last day of training *p=0.026). a
Improvement of escape latency with the number of trial days. b Bar
graph illustrating the time that each mouse group spent in one of the
four quadrants during the probe trial. Note that the Dnmt1+/+ mice
spent significantly more time on the correct quadrant than the rest (p=
0.003), whereas the Dnmt1+/− mice explored the four quadrants
randomly
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Fig. 5 Assessment of cognitive functions of Dnmt1+/+ and Dnmt1+/
− mice at 6 months of age by using the water maze test. Tests and
statistical analyses were performed as described in Fig. 2 except that
the testing lasted for 8 days, with a reversal of platform position on the
last day (day 8) of training. a Improvement of escape latency with the
number of trials. No statistically significant differences in the escape
latency time were present between the Dnmt1+/+ and Dnmt1+/−
mouse groups. However, the latencies of the reversal trials on day 8 were
significantly different (p=0.034) between the groups. The Dnmt1+/−
group learned the reversal on day 8 and showed a significant preference
for the correct quadrant (p=0.04), whereas the Dnmt1+/+ mice did not.
b Bar graphs illustrating the time that each group spent in one of the
four quadrants. Note that both Dnmt1+/+ mice and Dnmt1+/− mice
spent significantly more time (p=0.003) in the correct quadrant during
the probe trial on day 7, indicating intact learning and memory
functions at the tested age
Clin Epigenet (2011) 2:349–360 355on healthy aging outcome by monitoring several major aging
phenotypes including longevity, body composition changes,
and cognitive functions. The results suggested that reduction
in global DNA methylation, due to a heterozygous knockout
ofDnmt1,hadadversehealtheffectsduringtheagingprocess.
The significant decrease in BMD in Dnmt1+/− mice as
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Fig. 6 Assessment of cognitive functions between Dnmt1+/+ and
Dnmt1+/− mice by Barnes maze at 12 months of age. The same
groups of mice as in Fig. 3 were used for this test, and statistical
analyses were performed as described in Fig 2. a Improvement of
escape latency with the number of trial days. Dnmt1+/− mice had
worse cognitive performance at the beginning of the test as well as at
the end of the test (p=0.038), although their learning ability and
relative short-term memories were not severely impaired. b Graphs
illustrating the typical path of a mouse to escape from the maze on
days 1 and 5 of the experiment. The Dnmt1+/+ mice escaped more
efficiently from the maze than Dnmt1+/− mice on both days
 Fig. 7 Confirmation of impaired cognitive functions in Dnmt1+/− mice
vs. Dnmt1+/+ mice by using eight-arm radial water maze at 18 months of
age. The same groups of mice as in Fig. 3 were used for this test, and
statistical analyses were performed as described in Fig 2. a Improvement
of escape latency over the five trial days. Dnmt1+/− mice have a much
worse cognitive performance at the beginning of the test as well as at the
end of the test (#p<0.001; *p<0.003), although their learning ability and
short-term memory were not impaired. b Graphs illustrating the typical
path for the mice to escape to the correct arm (containing the escape
platform) on days 1 and 5 of the experiment. The Dnmt1+/+ mice
escaped faster from the maze than Dnmt1+/− mice. c Comparison of the
time spent in each arm between the Dnmt1+/+ mice and Dnmt1+/− mice
in the probe trial at the end of the test (i.e., day 5). Note that Dnmt1+/−
mice spent significantly (p<0.03) less time in the correct arm than the
Dnmt1+/+ mice did
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suggests that Dnmt1 haploinsufficiency could cause prema-
ture aging effects. This is further evidenced by the relatively
poor cognitive function in the Dnmt1+/− mice as compared
with the Dnmt1+/+ mice in the learning and memory tests.
The elevated incidence of tumor formation in old Dnmt1+/−
mice is consistent with previous observations that mice
carrying a hypomorphic Dnmt1 allele display severe genomic
hypomethylation and are prone to the development of
aggressive T cell lymphomas at early ages (Gaudet et al.
2003). In contrast, Dnmt1 haploinsufficiency seemed to have
no significant impact on survival or mortality based on the
relatively small number of mice in our study for up to
22 months of age. Nevertheless, these observations are
consistent with previously published findings (Ray et al.
2006). As most of the mice were used in our longitudinal
aging experiments at different ages in this study, we were
limited to the availability of mice at a specific age for tissue
collection and gene expression analysis. So there are slight
variations in the age of mice used in behavioral test, 5-mdC
measurement, and gene expression analysis. Given that
aging is a continuous process, changes in both DNA
methylation and Dnmt1 gene expression are likely to follow
a consistent trend, which is also supported by our results.
Therefore, we do not think that these slight variations in age
should have any significant impact on the conclusions drawn
from these experiments. Taken together, our results highlight
the role of Dnmt1 in regulating the healthy aging process
through genomic methylation changes, and also provide
direct in vivo evidence in support of the reduced Dnmt1
expression as a major factor that leads to the early onset of
age-related health problems such as decreased BMD and
cognition decline.
BMD is known to decline in middle-aged and elderly
individuals as a result of the normal aging process. Age-
related bone loss (osteopenia), as measured by an overall
reduction in total BMD, is a natural physiological process
but can eventually lead to osteoporosis under pathological
conditions. Although osteoporosis can occur in men, it is
most common in women especially during post-
menopausal stage. A similar gender-specific difference in
age-related bone loss has also been reported in rodents
(Banu et al. 2002). Our results show that Dnmt1 haploin-
sufficiency leads to an early onset of reduction in BMD in
both male and female mice, suggesting that DNA methyl-
ation may function as an essential player in bone biology.
However, the mechanism by which this occurs is not clear.
Given that bone turnover is generally affected by the
balance between bone resorption (mediated by osteoclasts)
and bone formation (mediated by osteoblasts), it is
reasonable to assume that insufficient DNA methylation
activity weakens osteoblastic activity or enhances osteo-
clastic activity. It will be of great interest to identify the key
genes that regulate these two opposing processes whose
expressions are modulated by DNA methylation. Although
we have no clear evidence about what causes the reduced
body weight in Dnmt1+/− mice, it is possible that
insufficient methylation activity may adversely impact
tissue stem cell renewal and thus tissue growth rate
(Schlessinger and V an Zant 2001), which will be investi-
gated in our future studies.
Loss of genomic DNA methylation with age has been
observed in different tissues and cell types by assessing the
methylation status of various specific repetitive DNA
elements (Wilson and Jones 1983; Mays-Hoopes et al.
1986; Rath and Kanungo 1989). Our methylation analysis
by LC-MS allows the assessment of total genomic 5-mdC
content, which reveals that DNA methylation decreases
with normal aging and is also lower in Dnmt1+/− mouse
brain tissues than that in Dnmt1+/+ mouse brain tissues.
However, we have not characterized which genomic
regions or genes are preferentially affected. Further efforts
will be directed to identify such DNA elements and target
genes to provide more specific explanations to the
functional impact of Dnmt1 haploinsufficiency as reported
in this study. A recent study in elderly people reveals a
gradual age-dependent loss of genomic DNA methylation
within the same individual over an 8-year span (Bollati et
al. 2009). This longitudinal study provides important in
vivo evidence in humans supporting that loss of DNA
methylation indeed occurs with age under normal
physiological conditions. However, this loss of DNA
methylation appears to be consistently seen only in the
Alu repetitive regions but not in the LINE regions
(Bollati et al. 2009). In a previous study, total methylation
levels in Tcells were shown to decrease in early aging but
then increase with late aging in heterozygous Dnmt1-
deficient mice that demonstrated a delayed development of
autoimmunity (Y ung et al. 2001). It is intriguing to see
such a dynamic change in methylation patterns despite the
loss of expression of one copy of the Dnmt1 allele. In the
brain cortex and hippocampus, as examined in our study,
DNA methylation levels in Dnmt1+/− mice are clearly
lower than that in age-matched Dnmt1+/+ mice. Concom-
itantly, DNA methylation levels decrease with age in both
Dnmt1+/− and Dnmt1+/+ mice (Table 2). The discrepancy
between our results and previous findings may be due to
different tissue types studied as well as the differences in
methods used to analyze DNA methylation. It is
interesting to note that, however, the heterozygous
Dnmt1-deficient mice were shown to develop jejunal
apolipoprotein AII amyloidosis, confirming that Dnmt1
haploinsufficiency is indeed detrimental to healthy aging
due to the risk of amyloid deposition with age that might
eventually lead to late-onset Alzheimer’s disease (Ray et
al. 2006).
Clin Epigenet (2011) 2:349–360 357Aging in humans, as well as in experimental animals, is
associated with a slow deterioration of cognitive perfor-
mance especially in memory, reaction time, and reasoning
abilities (Gallagher and Rapp 1997; Grady and Craik 2000).
Analysis of DNA methylation patterns across 12 Alz-
heimer’s disease (AD) susceptibility loci in post-mortem
brain samples from late-onset AD patients revealed a
pronounced difference in DNA methylation from the
control that further increases with age, supporting a role
of aberrant DNA methylation drift in AD (Wang et al.
2008). Our results show that reduced global DNA methyl-
ation in the brain cortex and hippocampus is associated
with impaired memory function in the Dnmt1+/− mice
compared to the Dnmt1+/+ mice. This effect is, however,
more readily detectable in older animals (12-month and
older) than in young animals (6 months of age; Figs. 4 and
5). This age-dependent effect on long-term memory may be
attributed to the fact that a steep decline in brain cortex
DNA methylation did not occur in Dnmt1+/− mice until a
relatively late age (7 months, Table 2). It should be noted
that short-term memory was still intact in the old Dnmt1+/−
mice, i.e., they could still learn the task. Although we have
not directly addressed how DNA methylation loss contrib-
utes to cognitive decline, it is possible that a decreased
DNA methylation activity could compromise adult neuro-
genesis activity during aging and therefore slows the
generation of new functional neurons in the central nervous
system (Zhao et al. 2003). Although Dnmt1 is generally
highly expressed during S-phase in mitotic cells and is
downregulated in resting cells, post-mitotic neurons and
glia in the perinatal and adult brain are shown to have a
high level of Dnmt1 expression (Brooks et al. 1996; Goto et
al. 1994; Inano et al. 2000). It is proposed that Dnmt1
might be required to facilitate specific forms of DNA repair
in post-mitotic brain cells or required for the methylation of
mitotic precursor cells and their daughter cells (Feng et al.
2007). Thus, a decreased DNA methylation activity in the
brain might lead to improper methylation modification of
the genome of the newly generated neurons, and thus
results in their poor survival, integration, or inability to
form efficient connections with surrounding neurons.
Consistent with this idea, Dnmt1 deficiency in mitotic
CNS precursor cells resulted in DNA hypomethylation in
daughter cells that leads to their functional elimination from
the CNS (Fan et al. 2001). These findings provide
important cellular evidence to support the role of DNA
methylation in modulating the CNS cognitive function
during the aging process.
It is interesting to note that at 6 months of age, the
Dnmt1+/− mice learned the reversal task more quickly than
the Dnmt1+/+ mice following the four training sessions as
demonstrated by the probe trial data (Fig. 5). The Dnmt1+/+
mice kept on searching near the previously correct position,
whereas the Dnmt1+/− mice changed their strategy and
searched near the new correct location, indicating differences
in interactions between long-term and short-term memory
between these two groups of mice. Furthermore, both the
Dnmt1+/+ and the Dnmt1+/− mice learned the water maze
task equally well, indicating intact long-term memory of the
platform position. Dnmt1+/− mice did learn the new position
in four trials in 1 day, suggesting that they also have intact
short-term memory at 6 months of age. The interaction
between long-term (“old” platform position) and short-term
memory (“new” platform position) is, however, clearly
different between Dnmt1+/+ and Dnmt1+/− mice. At
12 months of age and later, however, the Dnmt1+/+ mice
are performing significantly better than the Dnmt1+/− mice,
indicating impaired memory function in Dnmt1+/− mice.
Interestingly, in the eight-arm water maze task at 18 months
of age, the Dnmt1+/+ mice appeared to remember the
task, i.e., they could find the escape platform quickly,
whereas the Dnmt1+/− mice did not remember this (note
the significant difference in the performance by these two
groups on the first day of training). This indicates that
there is a pronounced difference in the retention of long-
term memory encoding (i.e., the task of swimming to
find an escape platform) between these two groups of
mice at old ages. On the other hand, it should be noted
that the Dnmt1+/− mice improved in the task by the end
of the experiment, and the probe trial data indicate that
both groups learned the position of the escape platform
and searched primarily at the “correct” position. There-
fore, long-term memory formation (for at least a 24-h period)
fortheescapeplatformpositionisstillpresentinthesemice.It
is of interest to note that both groups of mice showed an age-
related decrease in swimming speed, i.e., from approximately
19 cm/s to approximately 12 cm/s.
In summary, the results from our study suggest that
the level of Dnmt1 activity is intimately involved in
regulating genomic methylation levels and age-related
physiological health conditions. We provide direct in
vivo evidence showing that an appropriate level and
activity of Dnmt1 are required to sustain a better health
condition and cognitive function. Although age-related
cognitive decline is considered a normal biological
process, individuals with mild cognitive impairment have
a much higher risk of developing Alzheimer’s disease
than the general population (Liu et al. 2003). Our
findings shed new insights into one of the important
mechanisms underlying such major age-related disease
etiology, and thus pave the way for further mechanistic
studies and molecular interventions in the future. Based on
these findings, it is tempting to explore the possibility of
slowing or even reversing age-related health deterioration
by enhancing Dnmt1 bioactivity through pharmacological
or dietary intervention.
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